Frontlight ResearchEarly access
Active, not recruitingNo phase
A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching Placebo
Key facts
- Who runs it
- ICM Co. Ltd.
- Where
- Australia2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 10 people enrolled
- Started
- 16 Mar 2023
- Expected to end
- Jul 2029
- Type of study
- Observational, 2 groups
- Treatments tested
- ICM-203
- Placebo
- Record updated
- 3 September 2026
Who can take part
- Age
- 50 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Previous receipt of ICM-203 or matching placebo
Who cannot take part
- None
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is an observational study of the long term safety and efficacy of ICM-203.
The 2 groups in the trial
- ICM-203
Participants who previously received ICM-203 in ICM-203 clinical studies
- Placebo
Participants who previously received placebo in ICM-203 clinical studies
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 3 September 2026